Oestradiol Exposure Early in Life Programs Daily and Circadian Activity Rhythms in Adult Mice.

Hormone signalling during critical periods organises the adult circadian timekeeping system by altering adult hormone sensitivity and shaping fundamental properties of circadian rhythmicity. However, the timing of when developmental oestrogens modify the timekeeping system is poorly understood. To test the hypothesis that alterations in postnatal oestrogenic signalling organise adult daily activity rhythms, we utilised aromatase knockout mice (ArKO), which lack the enzyme required for oestradiol synthesis. ArKO and wild-type (WT) males and females were administered either oestradiol (E) or oil (OIL) daily for the first 5 postnatal days (p1-5E and p1-5OIL , respectively) because this time encompasses the emergence of clock gene rhythmicity and light responsiveness in the suprachiasmatic nucleus, a bilateral hypothalamic structure regarded as the 'master oscillator'. After sexual maturation, gonadectomy and exogenous oestradiol supplementation, locomotor parameters were assessed. We determined that altered oestrogenic signalling in early life exerts organisational control over the expression of daily and circadian activity rhythms in adult mice. Specifically, p1-5E reduced total wheel running activity in male and female ArKO and female WT mice but had no effect on WT male activity levels. In females, wheel running was consolidated by p1-5E to the early versus late evening, a phenomenon characteristic of male mice. The time of peak activity was advanced by p1-5E in WT and ArKO females but not males. P1-5E shortened the length of the active phase (alpha) in WT males but had no effect on ArKO males or females of either genotypes. Finally, p1-5E altered the magnitude of photic-induced shifts, suggesting that developmental oestrogenic signalling impacts adult circadian functions. In the present study, we further define both a critical period of development of the adult timekeeping system and the role that oestrogenic signalling plays in the expression of daily and circadian activity rhythms throughout life.

ESR1 and ESR2 differentially regulate daily and circadian activity rhythms in female mice.

Estrogenic signaling shapes and modifies daily and circadian rhythms, the disruption of which has been implicated in psychiatric, neurologic, cardiovascular, and metabolic disease, among others. However, the activational mechanisms contributing to these effects remain poorly characterized. To determine the activational impact of estrogen on daily behavior patterns and differentiate between the contributions of the estrogen receptors ESR1 and ESR2, ovariectomized adult female mice were administered estradiol, the ESR1 agonist propylpyrazole triol, the ESR2 agonist diarylpropionitrile, or cholesterol (control). Animals were singly housed with running wheels in a 12-hour light, 12-hour dark cycle or total darkness. Estradiol increased total activity and amplitude, consolidated activity to the dark phase, delayed the time of peak activity (acrophase of wheel running), advanced the time of activity onset, and shortened the free running period (τ), but did not alter the duration of activity (α). Importantly, activation of ESR1 or ESR2 differentially impacted daily and circadian rhythms. ESR1 stimulation increased total wheel running and amplitude and reduced the proportion of activity in the light vs the dark. Conversely, ESR2 activation modified the distribution of activity across the day, delayed acrophase of wheel running, and advanced the time of activity onset. Interestingly, τ was shortened by estradiol or either estrogen receptor agonist. Finally, estradiol-treated animals administered a light pulse in the early subjective night, but no other time, had an attenuated response compared with controls. This decreased phase response was mirrored by animals treated with diarylpropionitrile, but not propylpyrazole triol. To conclude, estradiol has strong activational effects on the temporal patterning and expression of daily and circadian behavior, and these effects are due to distinct mechanisms elicited by ESR1 and ESR2 activation.

Circadian parameters are altered in two strains of mice with transgenic modifications of estrogen receptor subtype 1.

There are sex differences in free-running rhythms, activity level and activity distribution that are attributed, in part, to the action of gonadal hormones. We tested the hypothesis that non-classical estrogenic signaling pathways at estrogen receptor subtype 1 (ESR1) modify the amplitude and phase of activity. We used ESR1 knock-out mice (ERKO) and non-classical estrogen receptor knock-in mice (NERKI). ERKO animals are unable to respond to estrogen at the ESR1 and NERKI animals lack the ability to respond to estrogens via the estrogen response element-mediated pathway, but can still respond via non-classical mechanisms. We compared intact male and female ERKO, NERKI and wildtype (WT) mice with respect to total wheel-running activity, activity distribution across the 24-h day, phase angle of activity onset and free-running period (τ) and the duration of activity in constant conditions. WT females had significantly greater activity than WT males, and this activity was more consolidated to the dark phase of the light:dark cycle. These sex differences were absent in the NERKI and ERKO animals. Among females, NERKI and ERKO animals had greater activity during the light phase than WT counterparts. Additionally, we have identified a novel contribution of non-classical estrogen signaling pathways on the distribution of activity. Our data suggest that total activity is ESR1-dependent and daily activity patterns depend on both classical and non-classical actions of estrogens. These data will aid in identifying the mechanisms underlying sex differences in sleep-wake cycles and the influence of steroid hormones on circadian patterns.

Daily rhythms and sex differences in vasoactive intestinal polypeptide, VIPR2 receptor and arginine vasopressin mRNA in the suprachiasmatic nucleus of a diurnal rodent, Arvicanthis niloticus.

Diurnal and nocturnal animals differ with respect to the time of day at which the ovulatory surge in luteinizing hormone occurs. In some species this is regulated by the suprachiasmatic nucleus (SCN), the primary circadian clock, via cells that contain vasoactive intestinal polypeptide (VIP) and vasopressin (AVP). Here, we evaluated the hypothesis that chronotype differences in the timing of the luteinizing hormone surge are associated with rhythms in expression of the genes that encode these neuropeptides. Diurnal grass rats (Arvicanthis niloticus) were housed in a 12/12-h light-dark cycle and killed at one of six times of day (Zeitgeber time 1, 5, 9, 13, 17, 21; ZT 0 = lights-on). In-situ hybridization was used to compare levels of vip, avp and VIP receptor mRNA (vipr2) in the SCN of intact females, ovariectomized females, ovariectomized females given estradiol and intact males. We found a sex difference in vip rhythms with a peak occurring at ZT 13 in males and ZT 5 in intact females. In all groups avp mRNA rhythms peaked during the day, from ZT 5 to ZT 9, and had a trough in the dark at ZT 21. There was a modest rhythm and sex difference in the pattern of vipr2. Most importantly, the patterns of each of these SCN rhythms relative to the light-dark cycle resembled those seen in nocturnal rodents. Chronotype differences in timing of neuroendocrine events associated with ovulation are thus likely to be generated downstream of the SCN.

Calbindin and Fos within the suprachiasmatic nucleus and the adjacent hypothalamus of Arvicanthis niloticus and Rattus norvegicus.

The suprachiasmatic nucleus is the site of the primary circadian pacemaker in mammals. The lower sub paraventricular zone that is dorsal to and receives input from the suprachiasmatic nucleus may also play a role in the regulation of circadian rhythms. Calbindin has been described in the suprachiasmatic nucleus of some mammals, and may be important in the control of endogenous rhythms. In the first study we characterized calbindin-expressing cells in the suprachiasmatic nucleus and lower sub-paraventricular zone of nocturnal and diurnal rodents. Specifically, Rattus norvegicus was compared to Arvicanthis niloticus, a primarily diurnal species within which some individuals exhibit nocturnal patterns of wheel running. Calbindin-immunoreactive cells were present in the suprachiasmatic nucleus of Arvicanthis and were most concentrated within its central region but were relatively sparse in the suprachiasmatic nucleus of Rattus. Calbindin-expressing cells were present in the lower sub-paraventricular zone of both species. In the second study we evaluated Fos expression within calbindin-immunoreactive cells in nocturnal Rattus and in Arvicanthis that were either diurnal or nocturnal with respect to wheel-running. All animals were kept on a 12:12 light/dark cycle and perfused at either 4h after lights-on or 4h after lights-off. In the suprachiasmatic nucleus in both species, Fos expression was elevated during the day relative to the night but less than 1% of calbindin cells contained Fos in Arvicanthis, compared with 13-17% in Rattus. In the lower sub-paraventricular zone of both species, 9-14% of calbindin cells expressed Fos, and this proportion did not change as a function of time. Among Arvicanthis, the number of calbindin expressing neurons in the lower sub-paraventricular zone was influenced by an interaction between the wheel running patterns (nocturnal vs diurnal) and time of day. Thus, the number of calbindin-positive cells within the suprachiasmatic nucleus differed in Arvicanthis and Rattus, whereas the number of calbindin-positive cells within the lower sub-paraventricular zone differed in nocturnal and diurnal Arvicanthis. Our examination of R. norvegicus and A. niloticus suggests potentially important relationships between calbindin-containing neurons and whether animals are nocturnal or diurnal. Specifically, rats had more Fos expression in calbindin containing cells in the suprachiasmatic nucleus than Arvicanthis. In contrast, Arvicanthis exhibiting diurnal and nocturnal patterns of wheel-running differed in the number of calbindin-containing cells in the lower sub-paraventricular zone, dorsal to the suprachiasmatic nucleus.

Nocturnal and diurnal rhythms in the unstriped Nile rat, Arvicanthis niloticus.

In a laboratory population of unstriped Nile grass rats, Arvicanthis niloticus, individuals with two distinctly different patterns of wheel-running exist. One is diurnal and the other is relatively nocturnal. In the first experiment, the authors found that these patterns are strongly influenced by parentage and by sex. Specifically, offspring of two nocturnal parents were significantly more likely to express a nocturnal pattern of wheel-running than were offspring of diurnal parents, and more females than males were nocturnal. In the second experiment, the authors found that diurnal and nocturnal wheel-runners were indistinguishable with respect to the timing of postpartum mating, which always occurred in the hours before lights-on. Here they also found that both juvenile and adult A. niloticus exhibited diurnal patterns of general activity when housed without a wheel, even if they exhibited nocturnal activity when housed with a wheel. In the third experiment, the authors discovered that adult female A. niloticus with nocturnal patterns of wheel-running were also nocturnal with respect to general activity and core body temperature when a running wheel was available, but they were diurnal when the running wheel was removed. Finally, a field study revealed that all A. niloticus were almost exclusively diurnal in their natural habitat. Together these results suggest that individuals of this species are fundamentally diurnal but that access to a running wheel shifts some individuals to a nocturnal pattern.

Fos expression within vasopressin-containing neurons in the suprachiasmatic nucleus of diurnal rodents compared to nocturnal rodents.

The underlying neural causes of the differences between nocturnal and diurnal animals with respect to their patterns of rhythmicity have not yet been identified. These differences could be due to differences in some subpopulation of neurons within the suprachiasmatic nucleus (SCN) or to differences in responsiveness to signals emanating from the SCN. The experiments described in this article were designed to address the former hypothesis by examining Fos expression within vasopressin (VP) neurons in the SCN of nocturnal and diurnal rodents. Earlier work has shown that within the SCN of the diurnal rodent Arvicanthis niloticus, approximately 30% of VP-immunoreactive (IR) neurons express Fos during the day, whereas Fos rarely is expressed in VP-IR neurons in the SCN of nocturnal rats. However, in earlier studies, rats were housed in constant darkness and pulsed with light, whereas Arvicanthis were housed in a light:dark (LD) cycle. To provide data from rats that would permit comparisons with A. niloticus, the first experiment examined VP/Fos double labeling in the SCN of rats housed in a 12:12 LD cycle and perfused 4 h into the light phase or 4 h into the dark phase. Fos was significantly elevated in the SCN of animals sacrificed during the light compared to the dark phase, but virtually no Fos at either time was found in VP-IR neurons, confirming that the SCN of rats and diurnal Arvicanthis are significantly different in this regard. The authors also evaluated the relationship between this aspect of SCN function and diurnality by examining Fos-IR and VP-IR in diurnal and nocturnal forms of Arvicanthis. In this species, most individuals exhibit diurnal wheel-running rhythms, but some exhibit a distinctly different and relatively nocturnal pattern. The authors have bred their laboratory colony for this trait and used animals with both patterns in this experiment. They examined Fos expression within VP-IR neurons in the SCN of both nocturnal and diurnal A. niloticus kept on a 12:12 LD cycle and perfused 4 h into the light phase or 4 h into the dark phase, and brains were processed for immunohistochemical identification of Fos and VP. Both the total number of Fos-IR cells and the proportion of VP-IR neurons containing Fos (20%) were higher during the day than during the night. Neither of these parameters differed between nocturnal and diurnal animals. The implications of these findings are discussed.

Antimicrobial peptide expression is developmentally regulated in the ovine gastrointestinal tract.

Antimicrobial peptides are abundant components of the innate immune system present in species throughout the plant and animal kingdoms. In mammals, these immune peptides have been localized to epithelial tissues of the pig, mouse, rat, cow and human gastrointestinal tracts. We have identified in sheep two members of the beta-defensin antimicrobial peptide gene family that are expressed in a unique pattern throughout the gastrointestinal tract. Sheep beta-defensin 1 mRNA is the most prevalent from tongue to colon with the exception of the distal ileum, where beta-defensin 2 mRNA predominates. Sheep beta-defensin expression varies significantly between animals and is developmentally regulated both pre- and postnatally. These changes in antimicrobial peptide expression may correlate with anatomical differentiation as well as physiologic adaptations to extra-uterine life.

Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide.

Cathelin-related genes are characterized by the presence of a prepro sequence which is highly conserved both within and between species. 3' RACE analysis on sheep bone marrow RNA, using a primer based on a conserved cathelin family coding region, demonstrated the presence of at least three ovine cathelin-related cDNAs. One of these encodes a novel prepropeptide with a predicted C-terminal cleavage product RGLRRLGRKIAHG-VKKYGPTVLRIIRIAG. The chemically synthesized form of this 29 amino acid peptide is shown to be a thermostable, broad spectrum, bactericidal agent.